Trial intelligence / Profile preview

SUSA vs SSSA for Knee Arthroscopy

NCT01356797Phase 4

Key facts

Status: Completed
Start: May 2011
Primary completion: Sep 2011
Countries: 1
Sponsor: Hospital Quirónsalud Tenerife
Modality: Small Molecules

Drugs: levobupivacaine
Conditions: pain

Overview

Phase 4, randomised trial of levobupivacaine in pain (2 arms), sponsored by Hospital Quirónsalud Tenerife. Primary endpoint: Time to discharge home at 3 hours. Started May 2011; status: completed.

Design

2 arms

Study design: Randomized

SUSA Group
Selective Unilateral Spinal Anesthesia with 4 mg hyperbaric bupivacaine 0.5%
SSSA Group
Selective Sensory Spinal Anesthesia with 4 mg hypobaric levobupivacaine 0.13% with 10 mcg fentanyl

Endpoints

Primary

Time to discharge home3 hours

Secondary

Ambulation time after surgery3 hours

Beyond the preview

Go deeper on NCT01356797.

Full results, competitive context and analysis are in the Gosset platform.

Full results & analysis

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01356797.